OpenFilings
ORAMED PHARMACEUTICALS INC.
Form
8-K
Report Period
2024-10-07
Date Filed
2024-10-08
Time Filed
14:12:49
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
SECURITIES PURCHASE AGREEMENT, DATED OCTOBER 7, 2024, BY AND BETWEEN SCILEX HOLD
AMENDMENT NO. 1 TO SCILEX-ORAMED SPA, DATED OCTOBER 8, 2024, BY AND BETWEEN SCIL
TRANCHE B SENIOR SECURED CONVERTIBLE NOTE, DATED OCTOBER 8, 2024, ISSUED BY SCIL
WARRANT TO PURCHASE COMMON STOCK, DATED OCTOBER 8, 2024, ISSUED BY SCILEX HOLDIN
PURCHASE AND SALE AGREEMENT, DATED OCTOBER 8, 2024, BY AND AMONG SCILEX HOLDING
SECURITY AGREEMENT, DATED OCTOBER 8, 2024, BY AND AMONG SCILEX PHARMACEUTICALS I
SUBORDINATION AGREEMENT, DATED OCTOBER 8, 2024, BY AND AMONG SCILEX PHARMACEUTIC
CONSENT AND AMENDMENT, DATED AS OF OCTOBER 8, 2024, BY AND BETWEEN SCILEX HOLDIN
SUBSIDIARY GUARANTEE AMENDMENT, DATED OCTOBER 8, 2024, MADE BY CERTAIN OF SCILEX
AMENDED AND RESTATED SECURITY AGREEMENT, DATED OCTOBER 8, 2024, BY AND AMONG SCI
REST OF WORLD LICENSE TERM SHEET, DATED OCTOBER 8, 2024, BETWEEN ORAMED PHARMACE
AGREEMENT AMONG HOLDERS, DATED OCTOBER 8, 2024, BY AND BETWEEN ORAMED PHARMACEUT
PRESS RELEASE DATED OCTOBER 7, 2024
Filing on SEC Edgar